CEACAM8 and gastric adenocarcinoma: We concluded that the combination of CD66b+ tumor‐associated neutrophils and α‐SMA+ cancer‐associated fibroblasts could be used as an independent factor of outcome and to identify those gastric adenocarcinoma patients who might obtain advantage from postoperative chemotherapeutics.